GC
ANAC

Guggenheim Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Guggenheim Capital’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-60,711
Closed -$3.25M – 3042
2016
Q1 		$3.25M Sell
60,711
-15,604
-20% -$1.15M 0.01% 1247
2015
Q4 		$8.62M Sell
76,315
-11,430
-13% -$1.26M 0.03% 798
2015
Q3 		$10.3M Sell
87,745
-33,851
-28% -$4.42M 0.03% 731
2015
Q2 		$9.41M Buy
121,596
+3,604
+3% +$236K 0.02% 863
2015
Q1 		$6.83M Sell
117,992
-2,953
-2% -$125K 0.02% 1020
2014
Q4 		$3.9M Buy
+120,945
New +$3.63M 0.01% 1263
2014
Q1 		– Sell
-13,009
Closed -$219K – 3469
2013
Q4 		$219K Sell
13,009
-306
-2% -$4.23K ﹤0.01% 2808
2013
Q3 		$141K Buy
13,315
+1,498
+13% +$13.1K ﹤0.01% 2797
2013
Q2 		$66K Buy
+11,817
New +$71.5K ﹤0.01% 2877

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Guggenheim Capital's ANAC Position: Q2 2016 in Review

Guggenheim Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 60,711 shares — an estimated $3.25M sold.

Guggenheim Capital first reported a position in ANAC in Q2 2013 and held it in 9 quarters. The position peaked at $10.3M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Guggenheim Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Guggenheim Capital sold 60,711 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $3.25M.
  • Guggenheim Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 9 quarters.
  • Guggenheim Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $10.3M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Guggenheim Capital's 13F filing for Q2 2016, filed 15 Aug 2016.